Drug safety of frequently used drugs and substances for self-medication in COVID-19

D Baracaldo-Santamaría… - … advances in drug …, 2022 - journals.sagepub.com
During the COVID-19 pandemic, the behavior of self-medication has increased. The
dissemination of misleading information regarding the efficacy of certain drugs or …

[HTML][HTML] Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: A systematic review and meta-analysis

Q Zhou, S Zhao, L Gan, Z Wang, S Peng, Q Li… - …, 2022 - thelancet.com
Background There are concerns that the use of non-steroidal anti-inflammatory drugs
(NSAIDs) may increase the risk of adverse outcomes among patients with coronavirus …

[HTML][HTML] Arterial and venous thrombosis complicated in COVID-19: a retrospective single center analysis in Japan

S Oba, T Hosoya, M Amamiya, T Mitsumura… - Frontiers in …, 2021 - frontiersin.org
Background: Thrombosis is a characteristic complication in coronavirus disease 2019
(COVID-19). Since coagulopathy has been observed over the entire clinical course …

[HTML][HTML] Longitudinal multiparametric characterization of platelet dysfunction in COVID-19: Effects of disease severity, anticoagulation therapy and inflammatory status

AA Martyanov, AE Boldova, MG Stepanyan, OI An… - Thrombosis research, 2022 - Elsevier
Introduction Defects of platelet functional responses in COVID-19 were reported, but their
origin and pathophysiological significance are unclear. The objective of this study was to …

[HTML][HTML] Aspirin in COVID-19: Pros and cons

R Zareef, M Diab, T Al Saleh, A Makarem… - Frontiers in …, 2022 - frontiersin.org
Since its emergence, the COVID-19 pandemic has been ravaging the medical and
economic sectors even with the significant vaccination advances. In severe presentations …

[HTML][HTML] Atherosclerosis, cardiovascular disease, and COVID-19: a narrative review

C Vilaplana-Carnerero, M Giner-Soriano, À Dominguez… - Biomedicines, 2023 - mdpi.com
Atherosclerosis is a chronic inflammatory and degenerative process that mainly occurs in
large-and medium-sized arteries and is morphologically characterized by asymmetric focal …

[HTML][HTML] Antiplatelet therapy for patients with COVID-19: Systematic review and meta-analysis of observational studies and randomized controlled trials

X Zong, X Wang, Y Liu, Z Li, W Wang, D Wei… - Frontiers in …, 2022 - frontiersin.org
Background Hyperinflammation and coagulopathy are hallmarks of COVID-19 and
synergistically contribute to illness progression. Antiplatelet agents have been proposed as …

Prescription for COVID-19 by non-medical professionals during the pandemic in Colombia: a cross-sectional study

MJ Nino-Orrego… - … Advances in Drug …, 2022 - journals.sagepub.com
Background: The COVID-19 pandemic has led to an increase in the behavior of self-
medication (SM). Given the massive release of misleading information during the pandemic …

[HTML][HTML] Анализ влияния препаратов базовой терапии, применявшихся для лечения сопутствующих заболеваний в период, предшествующий инфицированию …

ЕИ Тарловская, АГ Арутюнов, АО Конради… - Кардиология, 2021 - lib.ossn.ru
Аннотация Цель Изучение влияния регулярного приема препаратов, назначенных
пациенту с целью лечения сердечно-сосудистых заболеваний (ССЗ) и других …

[HTML][HTML] Associations between the use of aspirin or other antiplatelet drugs and all-cause mortality among patients with COVID-19: A meta-analysis

W Su, H Miao, Z Guo, Q Chen, T Huang… - Frontiers in …, 2022 - frontiersin.org
Introduction: Whether aspirin or other antiplatelet drugs can reduce mortality among patients
with coronavirus disease (COVID-19) remains controversial. Methods: We identified …